Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy-Reference-Cited by-同舟云学术

Association Between BKPyV Serotype I Antibody Level and Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

Published:2017-10 Issue:8 Volume:30 Page:622-626
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Rossi Francesca¹,Prosperini Luca²,De Rossi Nicola³,Capra Ruggero³,Rivanera Daniela¹,Li Xiuhong⁴,Cinque Paola⁵,Passeri Laura⁵,Pozzilli Carlo²,Viscidi Raphael⁶

Affiliation:

1. Department of Public Health and Infectious Diseases, Sapienza University of Rome, Rome, Italy.

2. Department of Neurology and Psychiatry, Sapienza University of Rome, Rome, Italy.

3. Multiple Sclerosis Center, Spedali Civili of Brescia, Brescia, Italy.

4. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

5. Clinic of Infectious Diseases, San Raffaele Hospital, Milan, Italy.

6. Department of Pediatrics, Johns Hopkins School of Medicine, Baltimore, Maryland.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2017.0039

Reference22 articles.

1. Epidemiology and prognosis of AIDS-associated progressive multifocal leukoencephalopathy in the HAART era

2. Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies

3. PML diagnostic criteria

4. Progressive Multifocal Leukoencephalopathy in Patients with HIV Infection

5. Markers of JC virus infection in patients with multiple sclerosis under natalizumab therapy

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Understanding Progressive Multifocal Leukoencephalopathy Risk in Multiple Sclerosis Patients Treated with Immunomodulatory Therapies: A Bird’s Eye View;Frontiers in Immunology;2018-02-02